Bradley Herring - 05 Jan 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Financial Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
ENFN
Transactions as of
05 Jan 2023
Transactions value $
$0
Form type
4
Filing time
09 Jan 2023, 16:36:56 UTC
Previous filing
21 Dec 2022
Next filing
10 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +40,688 +23% $0 215,688 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 13,563, 13,563 and 13,562 RSUs will vest on January 5, 2024, January 5, 2025 and January 5, 2026, respectively.